IARS Antikörper (AA 812-1056)
Kurzübersicht für IARS Antikörper (AA 812-1056) (ABIN7876903)
Target
Alle IARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 812-1056
-
Verwendungszweck
- IARS1 Antibody / Isoleucine--tRNA ligase, cytoplasmic
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- An E.coli-derived human recombinant protein (amino acids E812-E1056) was used as the immunogen for the IARS1 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the IARS1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the IARS1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- IARS (Isoleucyl-tRNA Synthetase (IARS))
-
Andere Bezeichnung
- IARS1
-
Hintergrund
- Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Alternatively spliced transcript variants have been found.
-
UniProt
- P41252
Target
-